Graubard, Barry I.
National Cancer Institute (NCI),
United States
2024 Rank: 41825
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Epidemiology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 64 out of 9875 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 41825 | 46656 |
| Total Cites | 2441 | 2537 |
| H-index | 24 | 25 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 55 | 56 |
| Number of Single+First+Last Authored Papers | 134 | 134 |
| Total Cites to Single+First+Last Authored Papers | 571 | 575 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2239 | 2307 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.10 |
| Self-Citation Percentage |
3.78%
|
|
Graubard, Barry I.
National Cancer Institute (NCI),
United States
2022 Rank: 38605
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Epidemiology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 76 out of 9365 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 38605 | 43515 |
| Total Cites | 2350 | 2479 |
| H-index | 23 | 23 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 60 | 61 |
| Number of Single+First+Last Authored Papers | 128 | 128 |
| Total Cites to Single+First+Last Authored Papers | 652 | 662 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2114 | 2197 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.13 |
| Self-Citation Percentage |
5.20%
|
|
Graubard, Barry I.
National Cancer Institute (NCI),
United States
2021 Rank: 42712
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Epidemiology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 91 out of 9307 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 42712 | 45880 |
| Total Cites | 3513 | 3738 |
| H-index | 26 | 28 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 89 | 95 |
| Number of Single+First+Last Authored Papers | 125 | 125 |
| Total Cites to Single+First+Last Authored Papers | 1087 | 1107 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3195 | 3332 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.12 |
| Self-Citation Percentage |
6.02%
|
|
Graubard, Barry I.
National Cancer Institute,
United States
2020 Rank: 34702
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Epidemiology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 76 out of 9540 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 34702 | 40687 |
| Total Cites | 2762 | 2966 |
| H-index | 24 | 24 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 70 | 74 |
| Number of Single+First+Last Authored Papers | 123 | 123 |
| Total Cites to Single+First+Last Authored Papers | 891 | 911 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2473 | 2591 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.14 |
| Self-Citation Percentage |
6.88%
|
|